California’s ProgenaBiome recently received the greenlight from the U.S. Food and Drug Administration (FDA) for two
Rain Therapeutics a privately held, clinical stage biotechnology company focused on targeted therapies for patients
Inversago Pharma announced it has secured a US$35 million Series B financing round led by Forbion, with ...
Daina Graybosch, a top life science research analyst at SVB Leerink covering Immuno-Oncology, recently communicated
Obesity represents big business and big problems. The condition has essentially tripled since the 1970s as raising ...
Investor Watch Series
No results found.